Point72 Hong Kong’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,517
Closed -$8K 2020
2022
Q1
$8K Buy
+2,517
New +$8K ﹤0.01% 1148
2021
Q4
Sell
-610
Closed -$2K 1917
2021
Q3
$2K Sell
610
-1,016
-62% -$3.33K ﹤0.01% 1285
2021
Q2
$7K Buy
+1,626
New +$7K ﹤0.01% 1219
2021
Q1
Sell
-9,868
Closed -$57K 1757
2020
Q4
$57K Buy
+9,868
New +$57K ﹤0.01% 731
2020
Q3
Sell
-10,402
Closed -$36K 1607
2020
Q2
$36K Buy
10,402
+9,513
+1,070% +$32.9K ﹤0.01% 788
2020
Q1
$1K Sell
889
-1,472
-62% -$1.66K ﹤0.01% 885
2019
Q4
$5K Buy
2,361
+2,093
+781% +$4.43K ﹤0.01% 1035
2019
Q3
$1K Buy
+268
New +$1K ﹤0.01% 927
2018
Q3
Sell
-3,835
Closed -$51K 1238
2018
Q2
$51K Buy
+3,835
New +$51K 0.02% 422